CD81 and OCLN double transgenic mouse and its construction methods
US9510570B2 · kind B2 · utility
1Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2014 |
| Grant date | Dec 6, 2016 |
| Priority date | — |
| Expiry date | Jun 24, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/0337
- WIPO fieldOther special machines
- WIPO sectorMechanical engineering
Abstract
The present invention provides a CD81 and OCLN double transgenic mouse and its construction method and use. The double transgenic mouse can be used to constitute acute and chronic HCV infection in a mouse model.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.